Chairs: Frank Lin & Dinny Graham
INVITED SPEAKERS: PASCAL MANCUSO & LOUISE EMMETT
Title to be confirmed (#48)
11:15 AM
PSMA theranostics: Where to Next? (#49)
11:35 AM
Comparing theory-based and non-theory-based implementation approaches to inform successful genomic medicine strategies in practice: a two-arm parallel randomised clinical trial for improving tumour testing and genetics services referral for Lynch syndrome. (#50)
11:55 AM
Treatment response assessment with quantitative imaging biomarkers in prostate cancer treated with radiation and androgen deprivation therapy (#51)
12:05 PM
Identifying synergistic combinations with the BCL2 inhibitor venetoclax for high-risk neuroblastoma (#52)
12:15 PM
Extracting Performance Status from Clinical Notes: Application Across Multiple Cancer Sites (#53)
12:25 PM
Perspectives of health professionals and patients on implementation of a predictive model of response to immunotherapies in advanced melanoma (#54)
12:35 PM
Targeted delivery of PEGylated liposomal doxorubicin by bispecific antibodies improves treatment of childhood leukaemia. (#55)
12:45 PM